Patients With Cancer

Oncology
1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
1
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Philogen
PhilogenItaly - Monteriggioni
1 program
1
131I-L19SIP RadioimmunotherapyPhase 1/21 trial
Active Trials
NCT01242943Terminated34Est. May 2011

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Philogen131I-L19SIP Radioimmunotherapy

Clinical Trials (1)

Total enrollment: 34 patients across 1 trials

NCT01242943Philogen131I-L19SIP Radioimmunotherapy

Radioimmunotherapy With 131I-L19SIP in Patients With Cancer

Start: Nov 2008Est. completion: May 201134 patients
Phase 1/2Terminated

Related Jobs in Oncology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space